Related Experiment Video
Updated: Sep 18, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Decoding the cancer microbiome: multi-omics, AI, and translational opportunities
Yuhan Sun1, Olivia J Cheng2,3, Anjun Ma1,4
1Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.
Abstract:
Multi-omics technologies, coupled with AI technologies, have the potential to enable the systematic investigation of complex cancer microbiome biology by uncovering informative patterns and associations across complementary datasets. Here, we review existing and emerging cancer microbiome data, discuss the development, interpretation, and validation of AI models as key considerations for their integration and analysis, and provide practical suggestions for improving the reliability and biological relevance of AI-driven discoveries. We further highlight the opportunities and challenges of translating these discoveries into clinical practice, emphasizing strategies to bridge the gap between research-oriented models and clinical implementations.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Genomics